Biotech

All Articles

Rakovina strengthens artificial intelligence concentrate with collab to decide on cancer intendeds

.5 months after Rakovina Rehabs rotated toward artificial intelligence, the cancer-focused biotech h...

Ascendis' dwarfism medicine smash hits in phase 3, endangers BioMarin

.Ascendis Pharma has actually emerged as a potential threat to BioMarin's Voxzogo, reporting phase 3...

Despite ph. 3 miss out on, Alkeus sees path ahead of time for eye condition asset

.Though Alkeus Pharmaceuticals' oral eye disease possession stopped working to substantially minimiz...

Kairos goes public with $6M IPO to cash tests of cancer cells medication

.With a triad of biotechs hitting the Nasdaq on Friday, it was actually quick and easy to miss a sma...

Vaccine and also Keytruda combination successful in squamous cell carcinoma

.Immune system checkpoint inhibitors are the superheroes of cancer treatment. Medications like Brist...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of notable leadership hirings, firings and also...

Regeneron's Opdualag opponent shows 57% reaction price

.Regeneron is actually back along with lasting follow-up for its LAG-3 prevention and PD-1 inhibitor...

AstraZeneca articles information on in-house rivals to AbbVie, Pfizer ADCs

.AstraZeneca has discussed an early take a look at the efficiency of its own in-house antibody-drug ...

iTeos- GSK's TIGIT celebrity presents significant remodeling

.After introducing a period 3 launch based upon favorable midstage end results, iTeos as well as GSK...

More collaborative FDA can speed up uncommon disease R&ampD: record

.The FDA needs to be even more available as well as collective to release a rise in commendations of...